Mar. 01, 2011
NewsCompany News

immatics Appoints Dr. Harald Stock

immatics biotechnologies, a late-stage biopharmaceutical company developing therapeutic vaccines that are active against cancer, today announced the appointment of Dr. Harald F. Stock to the board of directors, effective February 2011.

Harald Stock has been Chief Executive Officer of the Grünenthal Group since January 2009. Previously, he was Chairman and Managing Director of the German DePuy Group, the orthopeadics division of Johnson & Johnson, from 2006 to the end of 2008. Between April and December 2008, he also represented Johnson & Johnson on the Board of BVMed, the German Medical Technology Industry Association.

Dr. Stock held senior management positions at Roche before being appointed Senior Vice President of the global Near Patient Testing Diagnostics Business in Graz, Austria in 2005. Dr. Stock holds degrees in Chemistry and Business Administration and has a PhD in chemistry from the University of Heidelberg.

Register now!

The latest information directly via newsletter.

To prevent automated spam submissions leave this field empty.